ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

HAE Haemonetics Corp

84.66
-1.39 (-1.62%)
Jun 14 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 350,896
Bid Price
Ask Price
News -
Day High 85.59

Low
70.74

52 Week Range

High
97.97

Day Low 84.26
Share Name Share Symbol Market Stock Type
Haemonetics Corp HAE NYSE Common Stock
  Price Change Price Change % Share Price Last Trade
-1.39 -1.62% 84.66 18:59:39
Open Price Low Price High Price Close Price Previous Close
85.44 84.26 85.59 84.66 86.05
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
7,526 350,896 US$ 84.73 US$ 29,731,059 - 70.74 - 97.97
Last Trade Type Quantity Price Currency
18:34:50 40 US$ 84.50 USD

Haemonetics Corp Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
4.3B 50.79M - 1.31B 117.56M 2.31 36.59
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Haemonetics News

Date Time Source News Article
6/07/202415:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
6/07/202405:31Edgar (US Regulatory)Form ARS - Annual Report to Security Holders
6/07/202405:30Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting..
6/07/202405:26Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statements
5/29/202416:44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/29/202416:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/29/202416:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/29/202416:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/29/202416:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/29/202416:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/29/202415:06Edgar (US Regulatory)Form 8-K - Current report
5/29/202410:06Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No HAE Message Board. Create One! See More Posts on HAE Message Board See More Message Board Posts

Historical HAE Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week86.6487.6383.3385.47624,286-1.98-2.29%
1 Month94.8295.8282.88587.72778,363-10.16-10.72%
3 Months80.8197.9779.7988.02555,4563.854.76%
6 Months90.1197.9770.7483.53494,635-5.45-6.05%
1 Year87.0497.9770.7485.01389,752-2.38-2.73%
3 Years60.2197.9743.5072.18445,60224.4540.61%
5 Years111.61142.1143.5083.65478,501-26.95-24.15%

Haemonetics Description

Haemonetics Corp sells products used to process, handle, and analyze blood. The firm sells products in three categories: Plasma, Blood Center and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, and anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood. Hospital, which is comprised of Hemostasis Management, Cell Salvage, Transfusion Management and Vascular Closure products, includes devices and methodologies for measuring coagulation characteristics of blood, surgical blood salvage systems, specialized blood cell processing systems and disposables, blood transfusion management software and vascular closure devices.

Your Recent History

Delayed Upgrade Clock